Establishment of a reflux esophago-laryngitis model in rats

Digestive Diseases and Sciences

Volumn 56, Issue 5, 2011, Pages 1299-1308

  Asaoka, Daisuke ^a   Nagahara, Akihito ^a   Oguro, Masako ^a   Mori, Hiroki ^a   Nakae, Kosaburo ^a   Izumi, Yuko ^a   Osada, Taro ^a   Hojo, Mariko ^a   Otaka, Michiro ^a   Watanabe, Sumio ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Laryngopharyngeal reflux disease (LPRD); Proton pump inhibitor; Reflux esophagitis; Reflux laryngitis

Indexed keywords

INTERLEUKIN 1BETA; RABEPRAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DUODENUM; HISTOPATHOLOGY; LARYNGITIS; LEUKOCYTE; MALE; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; REFLUX ESOPHAGITIS; REFLUX ESOPHAGOLARYNGITIS; SCORING SYSTEM; SHAM PROCEDURE; THICKNESS;

ANIMALS; ARYTENOID CARTILAGE; CYTOKINES; DISEASE MODELS, ANIMAL; ESOPHAGITIS, PEPTIC; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION REGULATION; LARYNGEAL MUCOSA; LARYNGITIS; MALE; RATS; RATS, WISTAR; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 79955618399     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1431-y     Document Type: Article

References (34)

1. Vaezi MF, Hicks DM, Abelson TI, Richter JE. Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol. 2003;1:333-344. (Pubitemid 37248052)
2. Ford CN. Evaluation and management of laryngopharyngeal reflux. JAMA. 2005;294:1534-1540. (Pubitemid 41362691)
3. Watanabe S, Hojo M, Nagahara A. Metabolic syndrome and gastrointestinal diseases. J Gastroenterol. 2007;42:267-274. (Pubitemid 46681700)
4. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900-1920.
5. Park W, Hicks DM, Khandwala F, et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope. 2005;115:1230-1238. (Pubitemid 40962361)
6. Koufman JA, Weiner GJ, Wallace CW, Castell DO. Reflux laryngitis and its sequela. J Voice. 1988;2:78-79.
7. Carrau RL, Khidr A, Crawley JA, Hillson EM, Davis JK, Pashos CL. The impact of laryngopharyngeal reflux on patient-reported quality of life. Laryngoscope. 2004;114:670-674. (Pubitemid 38548778)
8. Wiener GJ, Koufman JA, Wu WC, Cooper JB, Richter JE, Castell DO. Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-h ambulatory pH monitoring. Am J Gastroenterol. 1989;84:1503-1508. (Pubitemid 20040052)
9. Deschner WK, Benjamin SB. Extraesophageal manifestations of gastroesophageal reflux disease. Am J Gastroenterol. 1989;84:1-5. (Pubitemid 19042986)
10. Asaoka D, Nagahara A, Oguro M, et al. Characteristic pathological findings and effects of ecabet sodium in rat reflux esophagitis. World J Gastroenterol. 2009;15:3480-3485.
11. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope. 2001;111:1313-1317. (Pubitemid 32730172)
12. Maronian N, Haggitt R, Oelschlager BK, et al. Histologic features of reflux-attributed laryngeal lesions. Am J Med. 2003;115(suppl 3A):105S-108S.
13. Nino G, Savchenko O, Vastola P, et al. Lipid laden macrophage indices and reflux finding score in canine gastroesophageal reflux model. Pediatr Pulmonol. 2007;42:1181-1186. (Pubitemid 350231869)
14. Shimazu R, Kusano K, Kuratomi Y, Inokuchi A. Histological changes of the pharynx and larynx in rats with chronic acid reflux esophagitis. Acta Otolaryngol. 2008;18:1-7.
15. Omura N, Kashiwagi H, Chen G, Suzuki Y, Yano F, Aoki T. Establishment of surgically induced chronic acid reflux esophagitis in rats. Scand J Gastroenterol. 1999;34:948-953. (Pubitemid 29512861)
16. Asaoka D, Miwa H, Hirai S, et al. Altered localization and expression of tight-junction proteins in a rat model with chronic acid reflux esophagitis. J Gastroenterol. 2005;40:781-790. (Pubitemid 41349233)
17. Izumi Y, Otaka M, Takahashi T, et al. Specific induction of a 72-kDa heat shock protein protects esophageal mucosa from reflux esophagitis. Life Sci. 2009;84:517-522.
18. Hamaguchi M, Fujiwara Y, Takashima T, et al. Increased expression of cytokines and adhesion molecules in rat chronic esophagitis. Digestion. 2003;68:189-197. Epub 2003 Dec 19. (Pubitemid 38250508)
19. Yasunaga Y, Shinomura Y, Kanayama S, et al. Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis. Gut. 1996;39:787-794. (Pubitemid 27049079)
20. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-h pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope. 1991;101(4 Pt 2 suppl 53):1-78.
21. Jacob P, Kahrilas PJ, Herzon G. Proximal esophageal pH-metry in patients with 'reflux laryngitis'. Gastroenterology. 1991;100:305-310.
22. Ward PH, Hanson DG. Reflux as an etiological factor of carcinoma of the laryngopharynx. Laryngoscope. 1988;98:1195-1199.
23. Corso MJ, Pursnani KG, Mohiuddin MA, et al. Globus sensation is associated with hypertensive upper esophageal sphincter but not with gastroesophageal reflux. Dig Dis Sci. 1998;43:1513-1517. (Pubitemid 28357271)
24. Torrico S, Kern M, Aslam M, et al. Upper esophageal sphincter function during gastroesophageal reflux events revisited. Am J Physiol Gastrointest Liver Physiol. 2000;279:G262-G267.
25. Gill GA, Johnston N, Buda A, et al. Laryngeal epithelial defenses against laryngopharyngeal reflux: investigations of E-cadherin, carbonic anhydrase isoenzyme III, and pepsin. Ann Otol Rhinol Laryngol. 2005;114:913-921. (Pubitemid 43030932)
26. Johnston N, Bulmer D, Gill GA, et al. Cell biology of laryngeal epithelial defenses in health and disease: further studies. Ann Otol Rhinol Laryngol. 2003;112:481-491. (Pubitemid 36712702)
27. Axford SE, Sharp N, Ross PE, et al. Cell biology of laryngeal epithelial defenses in health and disease: preliminary studies. Ann Otol Rhinol Laryngol. 2001;110:1099-1108. (Pubitemid 33140568)
28. Kawamura O, Aslam M, Rittmann T, Hofmann C, Shaker R. Physical and pH properties of gastroesophagopharyngeal refluxate: a 24-h simultaneous ambulatory impedance and pH monitoring study. Am J Gastroenterol. 2004;99:1000-1010. (Pubitemid 38917800)
29. Tokashiki R, Nakamura K, Watanabe Y, Yamaguchi H, Suzuki M. The relationship between esophagoscopic findings and total acid reflux time below pH 4 and pH 5 in the upper esophagus in patients with laryngopharyngeal reflux disease (LPRD). Auris Nasus Larynx. 2005;32:265-268. (Pubitemid 41058740)
30. Shaker R, Milbrath M, Ren J, et al. Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology. 1995;109:1575-1582.
31. Johnston N, Dettmar PW, Lively MO, et al. Effect of pepsin on laryngeal stress protein (Sep70, Sep53, and Hsp70) response: role in laryngopharyngeal reflux disease. Ann Otol Rhinol Laryngol. 2006;115:47-58. (Pubitemid 43132441)
32. Ludemann JP, Manoukian J, Shaw K, Bernard C, Davis M, al-Jubab A. Effects of simulated gastroesophageal reflux on the untraumatized rabbit larynx. J Otolaryngol. 1998;27:127-131. (Pubitemid 28340585)
33. Franchi A, Brogelli B, Massi D, Santucci M, De Campora E, Gallo O. Dilation of intercellular spaces is associated with laryngo- pharyngeal reflux: an ultrastructural morphometric analysis of laryngeal epithelium. Eur Arch Otorhinolaryngol. 2007;264:907-911. (Pubitemid 47025065)
34. Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology. 2009;137:1776-1784.